Reuters: Genentech, Biogen say Rituxan fails in lupus study

[chris]

Genentech, Biogen say Rituxan fails in lupus study
      

CHICAGO (Reuters) - Genentech Inc  and Biogen Idec Inc  said on Tuesday a key study of Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login